# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 17, "Arch Ophthalmol .", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasJournal> \"Arch Ophthalmol .\"."
1, PublicationYear, 18, 22, "1996", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasPublicationYear> \"1996\"."
6, Title, 52, 150, "A comparison of latanoprost and timolol in primary open - angle glaucoma and ocular hypertension .", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasTitle> \"A comparison of latanoprost and timolol in primary open - angle glaucoma and ocular hypertension .\"."
2, Latanoprost, 68, 79, "latanoprost", "", 
3, Timolol, 84, 91, "timolol", "", 
4, Primary_OpenAngleGlaucoma, 95, 124, "primary open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Primary_OpenAngleGlaucoma>."
5, OcularHypertension, 129, 148, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
6, Title, 151, 170, "A 12 - week study .", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasTitle> \"A 12 - week study .\"."
7, Duration, 153, 162, "12 - week", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#hasCTduration> \"12 - week\"."
8, Author, 171, 181, "Mishima HK", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasAuthor> \"Mishima HK\"."
9, Author, 190, 198, "Masuda K", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasAuthor> \"Masuda K\"."
10, Author, 201, 211, "Kitazawa Y", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasAuthor> \"Kitazawa Y\"."
11, Author, 214, 221, "Azuma I", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasAuthor> \"Azuma I\"."
12, Author, 224, 231, "Araie M", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasAuthor> \"Araie M\"."
13, Japan, 314, 319, "Japan", "", "<http://ctro/data#Population_97648> <http://ctro/data#hasCountry> <http://ctro/data#Japan>."
91, PublicationYear, 351, 355, "1996", "", 
21, ObjectiveDescription, 396, 647, "To evaluate the intraocular pressure ( IOP ) - reducing effect and the side effects of latanoprost ( PhXA41 ) , a new phenyl - substituted prostaglandin F2 alpha - isopropyl ester analogue , in patients with elevated IOP , using timolol maleate as the", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#hasObjectiveDescription> \"To evaluate the intraocular pressure ( IOP ) - reducing effect and the side effects of latanoprost ( PhXA41 ) , a new phenyl - substituted prostaglandin F2 alpha - isopropyl ester analogue , in patients with elevated IOP , using timolol maleate as the\"."
14, IOP, 412, 432, "intraocular pressure", "", 
15, IOP, 435, 438, "IOP", "", 
16, Latanoprost, 483, 494, "latanoprost", "", 
17, Latanoprost, 497, 503, "PhXA41", "", 
105982, ProstaglandinAnalogs, 535, 584, "prostaglandin F2 alpha - isopropyl ester analogue", "", 
97, Precondition, 590, 616, "patients with elevated IOP", "", "<http://ctro/data#Population_97648> <http://ctro/data#hasPrecondition> \"patients with elevated IOP\"."
19, IOP, 613, 616, "IOP", "", 
20, Timolol, 625, 640, "timolol maleate", "", 
22, ObjectiveDescription, 648, 664, "reference drug .", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#hasObjectiveDescription> \"reference drug .\"."
23, NumberPatientsCT, 686, 689, "184", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#hasNumberPatientsCT> \"184\"."
24, Primary_OpenAngleGlaucoma, 704, 733, "primary open - angle glaucoma", "", 
25, OcularHypertension, 737, 756, "ocular hypertension", "", 
26, Multicenter, 760, 778, "35 medical centers", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
27, Randomized, 800, 810, "randomized", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
28, DoubleBlind, 811, 826, "double - masked", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
29, Randomized, 853, 863, "randomized", "", 
30, DoseValue, 882, 889, "0 . 005", "", "<http://ctro/data#Medication_97656> <http://ctro/data#hasDoseValue> \"0 . 005\"."
32, Percentage, 890, 891, "%", "", "<http://ctro/data#Medication_97656> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
34, Latanoprost, 892, 903, "latanoprost", "", "<http://ctro/data#Latanoprost_97657> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost>. <http://ctro/data#Medication_97656> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_97657>."
36, Frequency, 904, 914, "once daily", "", "<http://ctro/data#Intervention_97663> <http://ctro/data#hasFrequency> \"once daily\"."
31, DoseValue, 918, 923, "0 . 5", "", "<http://ctro/data#Medication_97678> <http://ctro/data#hasDoseValue> \"0 . 5\"."
33, Percentage, 924, 925, "%", "", "<http://ctro/data#Medication_97678> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
35, Timolol, 926, 941, "timolol maleate", "", "<http://ctro/data#Medication_97678> <http://ctro/data#hasDrug> <http://ctro/data#Timolol>."
37, Frequency, 942, 953, "twice daily", "", "<http://ctro/data#Intervention_97685> <http://ctro/data#hasFrequency> \"twice daily\"."
38, Duration, 972, 980, "12 weeks", "", "<http://ctro/data#Intervention_97663> <http://ctro/data#hasDuration> \"12 weeks\". <http://ctro/data#Intervention_97685> <http://ctro/data#hasDuration> \"12 weeks\"."
39, IOP, 983, 1003, "Intraocular pressure", "", "<http://ctro/data#IOP_97692> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_97691> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_97692>."
40, Timolol, 1054, 1061, "timolol", "", 
44, TimePoint, 1067, 1091, "2 , 4 , 8 , and 12 weeks", "", 
43, TimePoint, 1071, 1091, "4 , 8 , and 12 weeks", "", 
42, TimePoint, 1075, 1091, "8 , and 12 weeks", "", 
41, TimePoint, 1083, 1091, "12 weeks", "", 
45, Latanoprost, 1117, 1128, "Latanoprost", "", 
46, IOP, 1137, 1140, "IOP", "", 
121, TimePoint, 1155, 1163, "12 weeks", "", "<http://ctro/data#Outcome_97696> <http://ctro/data#hasTimePoint> \"12 weeks\". <http://ctro/data#Outcome_97723> <http://ctro/data#hasTimePoint> \"12 weeks\"."
48, Reduction, 1167, 1172, "6 . 2", "", "<http://ctro/data#Outcome_97696> <http://ctro/data#hasChangeValue> \"6 . 2\"."
50, SdDevChangeValue, 1179, 1184, "2 . 7", "", "<http://ctro/data#Outcome_97696> <http://ctro/data#hasSdDevChangeValue> \"2 . 7\"."
52, mmHg, 1185, 1190, "mm Hg", "", "<http://ctro/data#Endpoint_97691> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
125, Mean, 1193, 1197, "mean", "", "<http://ctro/data#Mean_97693> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_97691> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_97693>."
56, RelativeReduction, 1211, 1217, "26 . 8", "", "<http://ctro/data#Outcome_97696> <http://ctro/data#hasRelativeChangeValue> \"26 . 8\"."
54, Timolol, 1230, 1237, "timolol", "", 
55, IOP, 1246, 1249, "IOP", "", 
49, Reduction, 1253, 1258, "4 . 4", "", "<http://ctro/data#Outcome_97723> <http://ctro/data#hasChangeValue> \"4 . 4\"."
51, SdDevChangeValue, 1265, 1270, "2 . 3", "", "<http://ctro/data#Outcome_97723> <http://ctro/data#hasSdDevChangeValue> \"2 . 3\"."
53, mmHg, 1271, 1276, "mm Hg", "", "<http://ctro/data#Endpoint_97691> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
57, RelativeReduction, 1279, 1285, "19 . 9", "", "<http://ctro/data#Outcome_97723> <http://ctro/data#hasRelativeChangeValue> \"19 . 9\"."
58, Latanoprost, 1306, 1317, "latanoprost", "", 
59, IOP, 1326, 1329, "IOP", "", 
60, Timolol, 1354, 1361, "timolol", "", 
105986, ObservedResult, 1368, 1420, "The main ocular side effects observed in both groups", "", "<http://ctro/data#Outcome_97765> <http://ctro/data#hasObservedResult> \"The main ocular side effects observed in both groups\". <http://ctro/data#Outcome_97792> <http://ctro/data#hasObservedResult> \"The main ocular side effects observed in both groups\"."
62, ConjunctivalHyperemia, 1426, 1448, "conjunctival hyperemia", "", "<http://ctro/data#Endpoint_97750> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#ConjunctivalHyperemia>."
63, Smarting, 1453, 1461, "smarting", "", "<http://ctro/data#Endpoint_97755> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Smarting>."
105985, ObservedResult, 1464, 1493, "The main systemic side effect", "", "<http://ctro/data#Outcome_97819> <http://ctro/data#hasObservedResult> \"The main systemic side effect\"."
105984, EndPointDescription, 1500, 1518, "reduced pulse rate", "", "<http://ctro/data#EndPointDescription_97761> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_97760> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_97761>."
65, PulseRate, 1508, 1518, "pulse rate", "", 
66, Timolol, 1561, 1568, "timolol", "", 
77, ConclusionComment, 1585, 1761, "The results of this study demonstrated that 0 . 005 % latanoprost taken once daily is well tolerated and more effective in reducing IOP than 0 . 5 % timolol taken twice daily .", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#hasConclusionComment> \"The results of this study demonstrated that 0 . 005 % latanoprost taken once daily is well tolerated and more effective in reducing IOP than 0 . 5 % timolol taken twice daily .\"."
68, DoseValue, 1629, 1636, "0 . 005", "", 
70, Latanoprost, 1639, 1650, "latanoprost", "", 
72, Frequency, 1657, 1667, "once daily", "", 
74, IOP, 1717, 1720, "IOP", "", 
69, DoseValue, 1726, 1731, "0 . 5", "", 
71, Timolol, 1734, 1741, "timolol", "", 
73, Frequency, 1748, 1759, "twice daily", "", 
78, ConclusionComment, 1762, 1851, "Thus , latanoprost may become an important choice for the medical treatment of glaucoma .", "", "<http://ctro/data#ClinicalTrial_97627> <http://ctro/data#hasConclusionComment> \"Thus , latanoprost may become an important choice for the medical treatment of glaucoma .\"."
75, Latanoprost, 1769, 1780, "latanoprost", "", 
76, Glaucoma, 1841, 1849, "glaucoma", "", 
79, PMID, 1910, 1917, "8694726", "", "<http://ctro/data#Publication_97616> <http://ctro/data#hasPMID> \"8694726\"."
